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Summary
Objectives: To examine the in situ distributions of vitamin D receptors (VDR) and matrix metalloproteinases (MMPs) in osteoarthritic cartilage
for comparison with non-arthritic, normal cartilage; and to assess the in vitro effects of 1,25 dihydroxyvitaminD3 (1,25(OH)2D3) on MMPs-1,
-3 and -9 and prostaglandin E2 (PGE2) production by cultures of human articular chondrocytes (HAC) shown to be VDR-positive.
Methods: Using immunohistochemistry VDR expression in different specimens of osteoarthritic cartilage (N=11) was compared to that in
normal cartilage (N=6), along with the immunodetection of MMPs-1, -3 and -9. The effects of 125(OH)2D3 on MMP and PGE2 production
by HAC in vitro, with and without stimulation by TNF or phorbol myristate acetate (PMA), was evaluated using ELISA methodology.
Results: VDR was demonstrated in HAC of all specimens of osteoarthritic cartilage, especially the superficial zone, whereas only two of five
normal cartilage specimens were VDR+ for a minor proportion of HAC. Immunolocalization of MMPs-1, -3 and -9 was often seen in areas
where chondrocytes were VDR+, and dual immunolocalization has demonstrated individual chondrocytes positive for both VDR and MMP-3
in situ. In vitro, 125(OH)2D3 alone had no effect on MMP-1, -9 and PGE2 production by HAC, but MMP-3 production was up-regulated by
125(OH)2D3 either with or without stimulation with TNF or PMA. By contrast the increased production of MMP-9 and PGE2 induced by
PMA was significantly suppressed by concomitant treatment with 125(OH)2D3.
Conclusions: The demonstration of VDR expression by HAC in osteoarthritic cartilage was often associated with sites where MMP
expression was prevalent, observations in contrast to their virtual absence in normal age-matched cartilage. Together with HAC in vitro
studies, the data suggests that 125(OH)2D3 contributes to the regulation of MMP and PGE2 production by HAC in osteoarthritic cartilage.
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Osteoarthritis (OA) is the major cause of disability in the
elderly yet little is known about its aetiopathogenesis1.
Early changes in osteoarthritic cartilage include fraying of
the superficial articular surface, the appearance of fibrilla-
tions and loss of cartilage proteoglycan (PG), each of which
becomes more prominent as the disease progresses, along
with the noticeable proliferation of chondrocytes into clus-
ters or ‘clones’2. Chondrolytic matrix metalloproteinases
(MMPs) are known to be important in osteoarthritic carti-
lage degradation3 where the focal expression of mRNA for
different MMPs by chondrocytes has been reported4.
Cytokines have been implicated in the complex regulation
of MMP production by chondrocytes5, and recent animal
studies have demonstrated a contributory role for vitamin
D3 in cartilage metabolism6–8.
The biologically active metabolite of vitamin D,
1,25dihydroxyvitaminD3, (1,25(OH)2D3), has a recog-
nized role in calcium and phosphorus metabolism and in a
variety of bone and mineral disorders such as osteoporosis
and rickets9. 1,25(OH)2D3 has other biological functions
including the regulation of cell proliferation, differentiation423and immune function10 brought about by its binding to
vitamin D receptors (VDR) that are expressed by a variety
of cell types such as monocytes, fibroblasts, activated
lymphocytes, various myeloid cells and also chondro-
cytes10,11. 1,25(OH)2D3 is purported to modulate
chondrocyte behavior within different zones of the growth
plate cartilage8,12 and has different effects on proteoglycan
and collagen synthesis, plasminogen activator expression
and the regulation of matrix metalloproteinase produc-
tion12,13. However, most information to date relates to
animal models or chondrocyte cultures derived from rat or
rabbit cartilage.
The recent demonstration of 1,25(OH)2D3 synthesis by
macrophages derived from the synovial fluid of patients
with inflammatory arthritis14,15, and the report that chondro-
cytes express VDR11 have suggested a contributory role
for 1,25(OH)2D3 in the aberrant behavior of chondrocytes
in OA. The present study has assessed the nature and
extent of VDR expression in osteoarthritic cartilage
together with the distributions of MMPs-1, -3 and -9 in situ.
In addition, we have examined the effects of 1,25(OH)2D3
on MMP production by human articular chondrocytes in
vitro, especially after activation by tumor necrosis factor-
(TNF-) and phorbol myristate acetate (PMA). Further,
since prostaglandin E2 (PGE2) is known to contribute to
bone remodeling/resorption and may modulate MMP
expression16,17, the effects of 1,25(OH)2D3 on PGE2
production by stimulated or ‘activated’ HAC has also been
examined.
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TISSUE SPECIMENS
Osteoarthritic knee tissues, from 30 different patients,
were removed at joint replacement surgery and transferred
to the laboratory in Hanks balanced salt solution (HBSS)
where cartilage was sampled from one tibial plateau of
each specimen within 60 min of operation. Similar age-
matched, macroscopically normal cartilage samples were
obtained from six early autopsy cases. Cartilage tissues
were sampled down to the subchondral bone, fixed in
Carnoy’s fixative for 2 h at 20°C, dehydrated in alcohol and
processed to paraffin wax. 5 m cartilage tissue sections
from the different specimens were stained with acidified
toluidine blue to determine histological grading. Each
specimen was examined by two independent assessors
and graded as 0, 1, 2 or 3, defined in Table I and adapted
from previous studies of clinical grading4,18. Sixteen speci-
mens were selected for an immunological study of VDR
and MMP distributions; these comprised 11 osteoarthritic
cartilage samples representing grades 1, 2, 3, and five
non-arthritic normal cartilage samples, grade 0. Two carti-
lage zones were identified, viz. a ‘superficial zone’ beneath
the articular surface and a ‘deep zone’ as previously
defined and illustrated2,4. The minimum number of cells
examined in any zone was 40 (range 40–225, mean value
95). All cartilage specimens were derived from individuals
in the age range 47–76 years (mean 68). 5 m sections
were cut and consecutive sections were immunostained for
VDR, MMP-1, MMP-3 and MMP-9, respectively.IMMUNOLOCALIZATION OF VDR
Tissue sections were pre-treated with 2M HCl at 37°C for
30 min, an antigen retrieval procedure recommended by
the supplier of the primary antibody. Non-immune rabbit
serum at 10% (v/v) in Tris-buffered saline (TBS) was
applied to the tissue sections for 20 min at 20°C. Rat
monoclonal antibody to chick VDR (known to cross-react
with human VDR; Cambridge BioScience, U.K.) was
applied for 2 h at 20°C after dilution to 5 g/ml in TBS. After
3×10 min washes in TBS, biotinylated rabbit antirat IgG
(DAKO Ltd, Cambridge, U.K.) diluted 1:200 in TBS was
applied to the sections for 45 min at 20°C. After further
washing in TBS, alkaline phosphatase (AP) conjugated
ABC (Avidin-Biotin Complex system, DAKO) was applied to
the sections for 45 min at 20°C. After further washing in
TBS the AP was developed using new fuchsin substrate to
give a red color. Sections were lightly counterstained with
toluidine blue before dehydrating and mounting in Histo-
mount permanent mountant (National Diagnostics, Hull,
U.K.).Table I
Frequency and distribution of vitamin D receptors (VDR) and matrix metalloproteinases (MMP)-1, -3 and -9 in osteoarthritic cartilage of
different disease grades
Specimen Grade Superficial zone Deep zone
VDR MMP-1 MMP-3 MMP-9 VDR MMP-1 MMP-3 MMP-9
698/2 3 + + + + + + + − + + + + −
771/1 3 + + + + + + + + + + − −
707/3 3 + + + + + + + + + + + + + + + + + + +
805/2 3 + + + + + + + + + + + + + + + + + + −
697/3 2 + + + + + + + + + + + + + + + + + +
699/3 2 + + + + + + + + + + + + − −
792/5 2 + + + + − + − − −
794/2 2 + + + − + + − − −
667/1 1 + + + + + + − + − − −
692/9 1 + + + + + − + + + −
804/2 1 + + + + + + + + + + + + −
Normals
NC/98/1 0 − − − − − − − −
NC/98/3 0 − + −/+ − − − − −
NC/98/6 0 + − − − + − − −
NC/98/8 0 − − −/+ − − − − nd
NC/99/2 0 + − − − − − − −
Key: Histological Grades are described as follows: Grade 0, normal matrix and chondrocyte morphology; Grade 1, uneven cartilage
surface with loss of metachromasia around enlarged chondrocytes of superficial zone, no fibrillations or chondrocyte clusters; Grade 2, some
surface erosion, fibrillations and small chondrocyte clusters in superficial zone, decreased metachromasia extending to deep zone; Grade
3, deeper surface erosions with fibrillations extending into deep zone, large number of chondrocyte clusters containing several cells, major
degenerative changes and loss of metachromasia in cartilage matrix.
Percentage of total chondrocytes in each zone positively stained for antigen: −, none; +, <10%; + +, 10–40%; + + +, 40–80%; + + + +,
>80%. nd=not done.
Statistical analyses (Student’s t-test) between osteoarthritic and normal specimens showed significant differences for the immunodetection
of VDR and the three MMPs, viz: VDR, P=0.0002*; MMP-1, P=0.003*; MMP-3, P=0.01*; MMP-9, P=0.05*. In addition , for the VDR+ and
MMP+ distributions between the superficial and deep zones of osteoarthritic cartilage, t-test P values were as follows: VDR, P=0.00003*;
MMP-1, P=0.0004*; MMP-3, P=0.002*; MMP-9, P=0.005*. *=statistically significant.IMMUNOLOCALIZATION OF MATRIX METALLOPROTEINASES -1, -3,
AND -9
Tissue sections were first incubated for 30 min with 10%
(v/v) donkey serum. Sheep polyclonal antibodies to
MMPs-1, -3 and -9 (Biogenesis, Poole, U.K.) were diluted
1:300, 1:500 and 1:250, respectively, in TBS and applied to
the sections for 2 h at 20°C followed by 3×10 min washes
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U.K.) was diluted 1:300 in TBS and applied to the sections
for 45 min at 20°C. After further washing AP-conjugated
ABC was applied and developed as described above.
Sections were counterstained in toluidine blue or Harris’s
haematoxylin and mounted.IMMUNOLOCALIZATION OF S-100 PROTEIN IN NORMAL CARTILAGE
SPECIMENS
The S-100 protein is a recognized marker for human
articular chondrocytes19 and its antibody was shown to
effectively access the chondrocytes of normal cartilage.
Tissue sections were first incubated for 30 min with 10%
(v/v) swine serum. Rabbit polyclonal antibody to S-100
protein (Dako, U.K.) was diluted 1:100 in TBS and applied
to the sections for 2 h at 20°C followed by 3×10 min
washes in TBS. Biotinylated swine antirabbit IgG (Dako,
U.K.) was diluted 1:300 in TBS and applied to the sections
for 45 min at 20°C. After further washing AP-conjugated
ABC was applied and developed as described above.
Sections were lightly counterstained in toluidine blue.DUAL IMMUNOLOCALIZATION OF VDR AND MMP-3
Tissue sections were pretreated with rabbit serum 10%
(v/v) for 30 min after which primary antibodies to VDR and
MMP-3, diluted in TBS as described above were applied
together at 4°C overnight. The sections were washed
3×10 min in TBS followed by incubation with a combination
of biotinylated rabbit antirat IgG and horseradish peroxi-
dase (HRP)-conjugated rabbit anti-sheep IgG for 1 h at
20°C. Following a further 3×10 min washes inTBS the
sections were incubated with AP-conjugated ABC complex
as described above for 45 min at 20°C. After further wash-
ing the HRP was developed first using 3-amino-9-ethyl-
carbazole (AEC; Sigma, U.K.) to give a red color, followed
by development of the AP using 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium (BCIP/NBT; Sigma, U.K.)
to give a blue-black color. Sections were mounted in
Immunomount aqueous mountant (Shandon, U.K.).IMMUNOHISTOCHEMISTRY CONTROLS
For controls the primary antibody was replaced by the
appropriate non-immune rat or sheep IgGs at concen-
trations corresponding to those of the primary antibodies.
Immunoadsorption of each antibody with its relevant puri-
fied antigen subsequently produced negative observations,
as described previously20,21.CELL CULTURES
Human articular cartilage from OA specimens was
enzymically digested to provide chondrocyte cultures as
previously described22. Primary chondrocyte cultures
grown to confluence in Dulbecco’s Modified Eagle’s
Medium (DMEM)+10% (v/v) fetal calf serum (FCS), were
harvested and seeded into 12-well culture dishes (Nunc,
Gibco, U.K.). Triplicate wells of sub-confluent HAC in
DMEM+2% FCS were treated with 125(OH)2D3 (10−8 M);
TNF (20 ng/ml); or TNF+125(OH)2D3 (20 ng/ml and
10−8 M, respectively) and incubated for 48 h at 37°C.
Similarly, triplicate wells of sub-confluent HAC inDMEM+2%FCS were treated with either PMA (25 ng/ml) or
PMA+1,25(OH)2D3 (25 ng/ml and 10−8 M, respectively).
The conditioned medium was collected after 48 h and
assayed for MMPs -1, -3, and -9, and prostaglandin E2(PGE2) using enzyme-linked immunosorbent assay(ELISA)
methodology. Cell numbers/well were counted at the end of
each experiment following 70% ethanol fixation and toluid-
ine blue staining (six fields of 1 mm2, total area=6 mm2).
Chondrocytes were also grown on glass coverslips in
DMEM+2% FCS and at various stages of confluence the
cells were briefly fixed in Carnoy’s fixative and immuno-
stained for VDR and S-100 as described for the cartilage
tissue sections. Cells were also immunostained for type II
cartilage collagen using rabbit polyclonal antibody
(Chemicon, Harrow, U.K.), diluted 1:20 and visualized with
the ABC detection system as described.ENZYME LINKED IMMUNOSORBENT ASSAYS (ELISA)
ELISA methodology was used to determine protein
levels of MMP-1 (collagenase 1, sensitivity: 0.8–50 ng/ml),
MMP-3 (stromelysin, sensitivity: 0.4–25 ng/ml) and MMP-9
(gelatinase B, sensitivity: 1.5–100 ng/ml) as previously
described23. PGE2 was measured using a competitive
binding assay kit purchased from R & D Systems Europe
Ltd, Abingdon, U.K., with a sensitivity range of 39–5000 pg/
ml. All ELISA results were calculated as ng or pg antigen/ml
culture medium/106 cells/48 h.ResultsIMMUNOHISTOCHEMISTRY
All eleven specimens of osteoarthritic cartilage showed
chondrocytes positive for the vitamin D receptor [Fig.
1(a),(b)], in contrast to the infrequent expression shown by
the control non-arthritic specimens [Fig. 1(c)]. The pro-
portion of VDR+ cells in osteoarthritic cartilage was vari-
able, not only between specimens but also within the
different zones of a single specimen (Table I). The two
zones described as the ‘superficial’ or ‘deep’ zone have
been reported by other studies2,4,24. We recognize that the
original ‘superficial’ zone of grade 1 lesions has mainly
been lost on progression to grade 3 and will not represent
the same tissue location as described for the non-arthritic
control cartilage specimens. We therefore use the term
‘superficial’ to describe the location at and just beneath the
articular surface of each specimen irrespective of the
grading, thereby allowing a comparative assessment for
VDR and the three MMPs (Table I). The most prominent
VDR+ staining of chondrocytes occurred within the super-
ficial zone of Grades 1 and 3 (Table I). Although some
chondrocytes were observed to be VDR+ within the deep
zones their numbers were consistently less than in the
superficial zone. However, the deep zone of grade 3
osteoarthritic cartilage usually contained markedly more
VDR+ cells than those for Grades 1 and 2. VDR expres-
sion was observed for both single chondrocytes [Fig. 1(a)]
and those found in typical OA chondrocyte clusters [Fig.
1(b)], but seldom in the specimens of normal articular
cartilage.
The extent of immunostaining for MMPs -1, -3 and -9
was variable in the osteoarthritic cartilage specimens [Fig.
1(d–f)]. MMP-1 was most prominent in Grade 3 superficial
zone cartilage, with the deep zone of Grades 1 and 2
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nent in the superficial zone of Grades 2 and 3 with
markedly less staining in the deep zone [Fig. 1(e)],
whereas MMP-9 immunostaining was less prevalent than
that for MMPs -1 and -3 [Fig. 1(f) and Table I]. By contrast
normal, non-arthritic cartilage revealed negligible immuno-
staining for MMP-1 [Fig. 1(g)]. Control tissue sections for
the immunostaining of VDR and MMPs consistently gave
negative results [Fig. 1(h) and (i), respectively]. The S-100
antibody effectively stained most chondrocytes in normal
cartilage thereby demonstrating that the weak immuno-
staining of these specimens was not due to lack of
penetration of antibodies (Fig. 2).
Table I summarizes the immunohistochemical results
obtained for VDR and each of the three MMPs; all four
antigens were significantly elevated in the osteoarthritic
compared with non-arthritic specimens, and especially so
for VDR. Whereas significant differences were observed
between the two cartilage zones for the extent of VDR and
MMP immunostaining, in general Grade 3 was greater than
2 and 1, and the superficial zone was greater than the deep
zone (see legend to Table I). Since these observations
suggested some association between VDR+ cells and
MMP expression in vivo, dual immunolocalization studies
have subsequently demonstrated that a proportion of
VDR+ cells were also producing MMP-3 [Fig. 1(j) and (k)];
these representing approximately 20% of chondrocytes in
the superficial zone of specimens 697/3 and 805/2. Recog-
nizing the unlikelihood that all VDR+ cells would be
responding to the locally available ligand 1,25(OH)2D3 at
specimen sampling time, the potential relationship of VDR
and MMP expression was further examined by assessing
the effects of 1,25(OH)2D3 on VDR and MMP expression
by HAC in culture.CHONDROCYTE CULTURES
Chondrocytes prepared from osteoarthritic cartilage
specimens and grown on coverslips were immunostained
for VDR. Whereas most chondrocytes of sub-confluent
HAC were VDR+ (Fig. 2), this decreased as the cells
approached confluence (Fig. 2). Thus to determine the
effects of 1,25(OH)2D3 on MMP and PGE2 production the
chondrocytes were used at sub-confluence to ensure VDR
expression by a major proportion of the cells. No noticeable
differences in VDR+ immunostaining was observed follow-
ing TNF- and PMA-stimulation of the HAC cultures com-
pared to controls, and all three preparations of OA derived
HAC were shown to be VDR+ at sub-confluence. In
addition, to confirm the chondrocytic phenotype of these
cultures, the cells were stained for both S-100 and type IIcartilage collagen, demonstrating the continued expression
of both antigens (Fig. 2).
The data in Fig. 3 represents the mean values from
experiments made with sub-confluent HAC from three
different specimens in which the responses to the treat-
ments were qualitatively similar. 1,25(OH)2D3 alone had
little effect on MMP-1, -9 or PGE2 production, but when
added to cells stimulated with TNF or PMA more marked
responses were observed (Fig. 3). 1,25(OH)2D3 had no
significant effect on TNF-stimulated MMP-1 production by
HAC, but when stimulated with PMA the resultant increase
in MMP-1 was significantly increased by the addition of
1,25(OH)2D3 (Fig. 3(a)). By contrast, MMP-3 production
by HAC was increased by 1,25(OH)2D3 treatment alone,
and its addition to TNF or PMA-stimulated cells signifi-
cantly enhanced MMP-3 production [Fig. 3(b)]. MMP-9 was
not produced by the HAC with or without 1,25(OH)2D3 or
TNF exposure. However, PMA stimulation significantly
increased MMP-9 production, this being reduced by
approximately 75% by the simultaneous addition of
1,25(OH)2D3 [Fig. 3(c)].
1,25(OH)2D3 had no effect on control values of PGE2
production by HAC in vitro, and TNF also showed only a
marginal increase. However, PMA stimulation of chondro-
cytes resulted in more than a five-fold increase in PGE2
production, this being reduced by more than 60% by the
concomitant addition of 1,25(OH)2D3 (Fig. 4).Fig. 1. Immunolocalization of the vitamin D receptor (VDR) and matrix metalloproteinases (MMPs) -1, -3 and -9 in osteoarthritic and normal,
age-matched cartilage. (A) Immunolocalization of VDR in osteoarthritic cartilage (grade 3). Positive cells stained red. Bar=65 m. (B) High
power micrograph of chondrocyte clusters within osteoarthritic cartilage (grade 3) immunostained for VDR. Note both positive (red stain) and
negative cells within the clusters. Bar=25 m. (C) Immunolocalization of VDR in normal cartilage (grade 0), Note only one cell in the field is
positively stained (arrow). Bar= 25 m. (D) Chondrocytes in osteoarthritic cartilage (grade 3) immunostained for MMP-1. Note cytoplasmic
positive staining (red). Bar=25 m. (E) Chondrocytes in osteoarthritic cartilage (grade 2) immunostained for MMP-3. Note cytoplasmic
positive staining (red). Bar=25 m. (F) Chondrocytes in osteoarthritic cartilage (grade 2) immunostained for MMP-9. Note both positively and
negatively stained cells. Bar=25 m. (G) Normal cartilage (grade 0) immunostained for MMP-1. Note absence of positively stained cells.
Bar=40 m. (H) Control tissue section for VDR staining in A, B and C (grade 2) treated with non-immune rat IgG. Bar=65 m. (I) Control
tissue section for MMP staining in D, E, F and G (grade 2) treated with non-immune sheep IgG. Bar=65 m. (J) and (K) Dual
immunolocalization of VDR (blue-black staining) and MMP-3 (reddish-brown) in osteoarthritic cartilage grade 2. Cells observed to be positive
for either one or both (arrrows) of the antigens. Bar=25 m. (L) Control tissue section for (J) and (K) treated with non-immune rat and sheep
IgG. Bar=25 m.Discussion
This study has demonstrated VDR expression by
chondrocytes within osteoarthritic cartilage, particularly
near to the articular surface and fibrillations, an observation
in contrast with normal cartilage specimens where VDR+
cells were rarely observed. This up-regulation of VDR+ in
osteoarthritic cartilage, an observation which was mirrored
in the cartilage derived from rheumatoid joints11, supports
the idea that 1,25(OH)2D3 may play a regulatory role in
the modulation of chondrocyte behavior in these patholo-
gies23,25. Recent studies have reported 1,25(OH)2D3 syn-
thesis by synovial fluid macrophages from patients with
inflammatory arthritis15, and that the receptor:metabolite
complex interacts with nuclear DNA to evoke a cellular
response26,27. Thus the marked nuclear staining observed
for some osteoarthritic cartilage specimens might well
suggest local activation of VDR+ chondrocytes. The extent
of VDR expression was variable between specimens, but
as yet the factors responsible for its regulation remain
unclear. Although a noticeable down-regulation of VDR in
chondrocytes approaching confluence in culture was
noted, little difference was observed for VDR expression
428 L. C. Tetlow and D. E. Woolley: Vitamin D and MMPs in osteoarthritisFig. 2. Immunolocalization of the chondrocyte markers S-100 and cartilage type II collagen, and VDR expression by human chondrocytes
in vitro. (A) S-100 immunostaining of normal cartilage chondrocytes (specimen NC/98/1). Bar=40 m. (A′) Control tissue section for S-100
staining in (A) treated with non-immune rabbit IgG. Bar=40 m. (B) S-100 immunostaining of sub-confluent HAC used in the in vitro
experiments. Bar=30 m. (B′) Cartilage type II collagen immunostaining of sub-confluent HAC as described for (B). Bar=30 m. (B″)
Negatively stained control sub-confluent culture of HAC treated with non-immune rabbit IgG for comparison with (B) and (B′). Bar=30 m.
(C) VDR+ immunostaining of sub-confluent culture of HAC used for in vitro experiments. Bar=30 m. (C′) VDR immunostaining of confluent
HAC culture. Note fewer cells positive for VDR than observed in (C). Bar=30 m. (C″) Negatively stained control HAC culture treated with
non-immune rat IgG for comparison with (C) and (C′). Bar=30 m.
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matrix metalloproteinase (MMP) -1, -3 and -9 production by human
articular chondrocytes (HAC) with and without stimulation by TNF
or PMA. (a) MMP-1 production by HAC (N=3) expressed as
ng/ml/106 cells/48 h showing values for control; +1,25(OH)2D3(10−8 M); +TNF (20 ng/ml); +TNF and 1,25(OH)2D3 (20 ng/ml
and 10−8 M, respectively); +PMA (25 ng/ml); and +PMA and
1,25(OH)2D3 (25 ng/ml and 10−8 M, respectively). Student t-test
showed significant differences (*) in MMP-1 production between
control and treatments, viz. +1,25(OH)2D3, P=0.01; +TNF,
P=0.003; +PMA, P=0.007. For TNF vs. TNF+1,25(OH)2D3,
P=0.05; and for PMA vs. PMA +1,25(OH)2D3, P=0.005. (b)
MMP-3 production by HAC (N=3) expressed as ng/ml/106 cells/
48 h, showing values for control and treatments as described in
(a). Student t-test showed significant differences (*) between
control and treatments, viz. +1,25(OH)2D3, P=0.01; +TNF,
P=0.03; +PMA, P=0.0002. For TNF vs. TNF+1,25(OH)2D3,
P=0.009; and for PMA vs. PMA+1,25(OH)2D3, P=0.03. (c)
MMP-9 production by HAC (N=3) expressed as ng/ml/106 cells/
48 h, showing values for control and treatments as described in
(a). Student t-test showed a significant difference (*)between the
PMA and PMA+1,25(OH)2D3 treated values, P=0.0054. All
values shown are mean±S.E.M.Fig. 4. Effects of 1,25(OH)2D3 on PGE2 production by human
articular chondrocytes with and without stimulation by TNF or
PMA. Mean values±S.E.M. are expressed as pg PGE2/ml/106 cells/
48 h and are shown for control; +1,25(OH)2D3 (10−8 M); +TNF(20 ng/ml); +TNF and 1,25(OH)2D3 (20 ng/ml and 10−8 M,
respectively); +PMA (25 ng/ml); and +PMA and 1,25(OH)2D3(25 ng/ml and 10−8 M, respectively). No statistically significant
differences were seen except between the PMA and PMA
+1,25(OH)2D3 treated cultures where P=0.05* (Student t-test).in situ between single chondrocytes and those in clusters;
most VDR+ differences being noted between the deep and
superficial zones of the same cartilage specimen.
The importance of MMPs in the pathophysiology of OA is
well established, both at protein and mRNA level4,28,29.
Collagenase 1 (MMP-1),collagenase 3 (MMP-13) and
stromelysin 1 (MMP-3) have all been demonstrated both
intra-and extracellularly in localized sites within osteoar-
thritic cartilage28,29. In this study MMPs -1, -3 and -9 were
demonstrated in cartilage sites where a proportion of the
chondrocytes were VDR+; an association which suggested
the possibility that 1,25(OH)2D3 could be involved in the
regulation of MMP and cytokine production at sites of
cartilage degradation in OA. Such a proposal could be
considered fortuitous and unrelated. However, the dual
localization study showing that some VDR+ cells were also
expressing MMP-3 suggests otherwise, this being sup-
ported to some extent by the in vitro studies where
1,25(OH)2D3 was shown to directly modulate MMP-3
production by HAC. For the in vitro chondrocyte studies it
was important to use VDR+ chondrocytes; thus the dem-
onstration that sub-confluent chondrocytes appeared to be
more positive than confluent cells was the prime reason for
using the former in the MMP and PGE2 experiments.
Previous studies regarding a relationship between
1,25(OH)2D3 and MMP regulation are mainly derived from
animal studies or experiments with immortalized cell lines.
For example, the interstitial collagenase gene expression in
rat chondrocytes was increased by the administration of
1,25(OH)2D3 to the animals7; 1,25(OH)2D3 significantly
up-regulated MMP-3 and MMP-2 in growth zone rat
chondrocytes12, and Lacraz et al.30 demonstrated the
discoordinate regulation of MMP-1 and -9 production by
human mononuclear phagocytes. A plenitude of agents are
known to have regulatory effects on MMP expression. The
cytokines IL-1 and TNF, and the prostanoids, such as
PGE2, have all been implicated in the enhanced production
of specific MMPs. The increased levels of MMP-1, -3 and -9
produced by IL-1-stimulated chondrocytes in vitro was
further enhanced upon addition of 1,25(OH)2D323, an
observation in accord with the TNF and PMA-induced
430 L. C. Tetlow and D. E. Woolley: Vitamin D and MMPs in osteoarthritisincrease for MMP-1 and MMP-3 reported here. By contrast,
the PMA-induced increase in MMP-9 and PGE2 production
by the same chondrocytes was suppressed by exposure to
1,25(OH)2D3, thereby indicating both enhancing and sup-
pressive roles for the vitamin D metabolite in the regulation
of these four chondrocyte products. Such disparate modu-
latory effects of 1,25(OH)2D3 on ‘activated’ chondrocytes
may be of relevance to the chondrolytic processes which
potentiate intrinsic cartilage damage.
1,25(OH)2D3 appears to have multifunctional properties
which relate to specific cell types. 1,25(OH)2D3 has differ-
ent effects on cytokine production and some inflammatory
responses. For example, 1,25(OH)2D3 acts synergistically
with bone matrix components to stimulate IL-1 production
by mononuclear cells31, inhibits IL-1 production by
myeloid cells32, and can regulate IL-1 production by rat
chondrocytes8. It seems plausible, therefore, that IL-1 and
TNF production by OA chondrocytes might be affected by
1,25(OH)2D3, but this has yet to be examined.
Prostaglandins are primary mediators in inflammation,
are recognized as having prominent roles in the immune
response, and PGE2 has been implicated in the poten-
tiation of MMP production in some cell cultures17.
1,25(OH)2D3 was reported to stimulate PGE2 production
by rat growth zone chondrocytes33, but in the present study
1,25(OH)2D3 had little effect on basal production of PGE2
by human chondrocytes. However, the enhanced PGE2
production observed following chondrocyte stimulation with
PMA was markedly suppressed by the simultaneous
addition of 1,25(OH)2D3.
In summary, our in vitro data suggest that 1,25(OH)2D3
has more pronounced effects on chondrocytes in states of
activation or proliferation, where it appears to modulate
MMP and PGE2 production. Whether ‘activated’ chondro-
cytes manifest increased VDR expression remains uncer-
tain at present, as does the nature of its regulation.
Although 1,25(OH)2D3 has the potential to modify MMP-1,
MMP-3, MMP-9 and PGE2 production by activated
chondrocytes in vitro, these represent only a minority of the
proteinases, prostanoids and cytokines elaborated by such
cells. Further studies are needed to examine the immu-
nomodulatory effects of this vitamin D metabolite on the
various chondrolytic or reparative processes of relevance
to the degenerative changes within osteoarthritic cartilage.Acknowledgments
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